Issue 24 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

15

No.

24

June 16, 1989Jun 16, 1989

Free

DOWNLOAD THE PDF

Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured

In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires

DCT Board Approves Recompetition f $4.3 Million CTEP Information System Contract

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

FDA, NCI Seek Compromise On Survival Endpoints

Recent Issues

Volume 52 | Issue 26 - July 02, 2026

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026